Ethnic disparities in the treatment of stage I non-small cell lung cancer.

RATIONALE Important variations exist in the treatment of non-small cell lung cancer. Because resection is the most effective treatment for patients with early disease, disparities in surgical rates can generate considerable differences in outcomes. OBJECTIVE We analyzed data from a national population-based registry to evaluate disparities in the treatment of Hispanic and white patients with stage I lung cancer and to assess the extent to which these inequalities explain survival differences. METHODS This study included 16,036 Hispanic and white patients with stage I lung cancer diagnosed between 1991 and 2000. Cases were identified from the Surveillance, Epidemiology, and End Results registry. Survival was compared among white and Hispanics using Kaplan-Meier curves. Stratified survival curves and Cox regression were used to evaluate whether inequalities in stage (IA vs. IB) and resection could explain survival differences. RESULTS Hispanics had worse overall and lung cancer-specific survival compared with whites (p = 0.04 and 0.008, respectively). Five-year lung cancer survival was 54% for Hispanics versus 62% for whites. Hispanics were more frequently diagnosed with stage IB disease (p = 0.0002) and less likely to undergo resection (p = 0.03). Among resected patients, survival was similar for the two groups, as it was among those who did not undergo unresection. After adjusting for surgery and stage, there was no difference in survival between groups. CONCLUSIONS Hispanics with stage I lung cancer had worse survival as compared with whites. These disparities are largely explained by lower rates of resection and higher probability of diagnosis at stage IB. Future work must delineate why Hispanics are receiving less surgery.

[1]  J. Whittle,et al.  Carotid Endarterectomy and Race: Do Clinical Indications and Patient Preferences Account for Differences? , 2002, Stroke.

[2]  R. Severson,et al.  Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database. , 2001, Chest.

[3]  K. Swallen,et al.  Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. , 1999, American journal of epidemiology.

[4]  J. Roth,et al.  Survival in early-stage non-small cell lung cancer. , 1995, The Annals of thoracic surgery.

[5]  J. Samet,et al.  Choice of cancer therapy varies with age of patient. , 1986, JAMA.

[6]  M. Sherman,et al.  Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus , 2003, Cancer.

[7]  K. Malone,et al.  Differences in breast cancer stage, treatment, and survival by race and ethnicity. , 2003, Archives of internal medicine.

[8]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[9]  D. Ettinger,et al.  Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.

[10]  E. Vrdoljak,et al.  Survival analysis of untreated patients with non-small-cell lung cancer. , 1994, Chest.

[11]  C B Begg,et al.  Racial differences in the treatment of early-stage lung cancer. , 1999, The New England journal of medicine.

[12]  Mary W. Carter.  Variations in hospitalization rates among nursing home residents: the role of discretionary hospitalizations. , 2003, Health services research.

[13]  Kathryn L O'Brien,et al.  Cancer Statistics for Hispanics, 2003 , 2003, CA: a cancer journal for clinicians.

[14]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[15]  P. Cleary,et al.  The effect of patients' preferences on racial differences in access to renal transplantation. , 1999, The New England journal of medicine.

[16]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[17]  T. E. King,et al.  Racial disparity in rates of surgery for lung cancer. , 1999, The New England journal of medicine.

[18]  H. Burdo,et al.  The autopsy as a measure of accuracy of the death certificate. , 1985, The New England journal of medicine.

[19]  Kevin Fiscella,et al.  Disparities in Health Care by Race, Ethnicity, and Language Among the Insured: Findings From a National Sample , 2002, Medical care.

[20]  G. Hutchins,et al.  Problems with proper completion and accuracy of the cause-of-death statement. , 2001, Archives of internal medicine.

[21]  N. Polissar,et al.  Social factors, treatment, and survival in early-stage non-small cell lung cancer. , 1998, American journal of public health.

[22]  K. Ness,et al.  Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. , 2003, JAMA.

[23]  C. Gatsonis,et al.  Racial differences in the use of revascularization procedures after coronary angiography. , 1993, JAMA.

[24]  C. Percy,et al.  Accuracy of cancer death certificates and its effect on cancer mortality statistics. , 1981, American journal of public health.

[25]  L. Clegg,et al.  Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. , 2002, Archives of internal medicine.

[26]  O. Miettinen,et al.  Small stage I cancers of the lung: genuineness and curability. , 2003, Lung cancer.

[27]  W F Taylor,et al.  Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.

[28]  S. Spiro,et al.  Lung cancer--where are we today? Current advances in staging and nonsurgical treatment. , 2002, American journal of respiratory and critical care medicine.